Skip to content
Wednesday, November 18, 2026
Explore UK creative insights, digital strategy, and media t…

Zimbabwe Turns Down ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Apprehensions

Health aid image
The proposed American funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a significant American healthcare agreement worth $367m (272 million pounds) over five years because of the United States' insistence on confidential data.

This move came to light following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".

An official representative later explained that the US was requesting genetic material for scientific study and commercial gain but was not willing to guarantee the benefits from any future treatments.

"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for continued negotiations to reach a deal acceptable to both sides so the nation's critical HIV programme can proceed.

Wider Background

This development follows a comparable case in Kenya, where a court blocked a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.

After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.

As per statements, Sixteen African countries have so far agreed to these new agreements, representing over $18.3bn in committed funds.

Details of the Rejected Agreement

The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment through US-supported programmes," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"Our nation was requested to share its biological resources and data for a long time, with no equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.

"Put simply, our nation would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our population should a future pandemic emerge."

National Interest and Global Health

He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures already established via the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.

"This system is designed to guarantee that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."

These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We are open to ongoing dialogue with our US partners on how future collaboration could be designed in a manner that respects the independence and interests of each country."

Medical Community Response

Medical experts said it recognised the government's concerns, but urged that talks should continue given that a large portion of the country's Aids initiatives relied on external financing.

"Where specific concerns exist, such as those relating to data governance or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," the group commented.

This impasse highlights the continuing tensions between receiving much-needed international aid and protecting national sovereignty in an increasingly interconnected world.

About the author

Amanda Mooney

A digital strategist and culture writer with over a decade of experience in UK media, specializing in creative innovation and tech trends.

Vision Culture Media

Type to search articles.